- HealthEquity reported an EPS of $1.08, beating the estimated $0.92 and showcasing a significant year-over-year improvement.
- The company’s revenue reached $325.84 million, exceeding expectations and marking an 8.6% increase from the previous year.
- Financial metrics reveal a P/E ratio of 63.21 and a debt-to-equity ratio of 0.52, indicating investor confidence and a healthy balance sheet.
HealthEquity, Inc. (NASDAQ:HQY) is a prominent player in the medical services industry, specializing in providing technology-enabled services that help consumers make informed healthcare decisions. The company offers a range of solutions, including health savings accounts (HSAs) and other consumer-directed benefits. HealthEquity competes with other firms in the healthcare technology sector, striving to deliver value to its customers and shareholders.
On September 2, 2025, HealthEquity reported earnings per share (EPS) of $1.08, surpassing the estimated $0.92. This represents a significant improvement from the $0.86 EPS reported in the same quarter last year. The earnings surprise for this quarter stands at +17.39%, highlighting the company’s ability to exceed market expectations consistently. In the previous quarter, HealthEquity also outperformed with an EPS of $0.97 against an anticipated $0.81, resulting in a +19.75% surprise.
HealthEquity’s revenue for the quarter ending in July 2025 reached $325.84 million, marking an 8.6% increase compared to the same period last year. This figure exceeded the Zacks Consensus Estimate of $318.81 million by 2.2%. The company’s consistent ability to surpass revenue estimates over the past four quarters underscores its strong market position and operational efficiency.
The company’s financial metrics provide further insights into its performance. HealthEquity has a price-to-earnings (P/E) ratio of approximately 63.21, indicating that investors are willing to pay over 63 times the company’s earnings for its shares. The price-to-sales ratio stands at about 6.18, suggesting that investors are paying $6.18 for every dollar of the company’s sales. These ratios reflect investor confidence in HealthEquity’s growth potential.
HealthEquity’s balance sheet also shows a healthy financial position. The debt-to-equity ratio is 0.52, indicating a moderate level of debt compared to equity. The current ratio of 4.06 suggests that the company has a strong ability to cover its short-term liabilities with its short-term assets. These metrics, combined with the company’s recent earnings performance, provide a comprehensive view of HealthEquity’s financial health and future prospects.
